- Fleischman MW, Budoff M, Zeb I, Li D, Foster T. NAFLD prevalence differs among hispanic subgroups: The Multi-Ethnic Study of Atherosclerosis. World journal of gastroenterology: WJG. 2014;20(17):4987. doi: 3748/wjg.v20.i17.4987. PMID: 24803810. PMCID: PMC4009531.
- Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2019;4(5):389-98. doi: 1016/S2468-1253(19)30039-1. PMID: 30902670.
- Hadi HE, Vettor R, Rossato M. Vitamin E as a treatment for nonalcoholic fatty liver disease: reality or myth? Antioxidants. 2018;7(1):12. doi: 3390/antiox7010012. PMID: 29337849. PMCID: PMC5789322.
- Pacana T, Sanyal AJ. Vitamin E and non-alcoholic fatty liver disease. Current opinion in clinical nutrition and metabolic care. 2012;15(6):641. doi: 1097/MCO.0b013e328357f747. PMID: 23075940. PMCID: PMC4984672.
- Taub R. Liver regeneration: from myth to mechanism. Nature reviews Molecular cell biology. 2004;5(10):836-47. doi: 1038/nrm1489. PMID: 15459664.
- Osman H, Gabr O, Lotfy S, Gabr S. Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian journal of medical microbiology. 2007;25(4):323-9. doi: 4103/0255-0857.37333. PMID: 18087079.
- Reboul E, Klein A, Bietrix F, Gleize B, Malezet-Desmoulins C, Schneider M, et al. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. Journal of Biological Chemistry. 2006;281(8):4739-45. doi: 1074/jbc.M509042200. PMID: 16380385. PMCID: PMC2045115.
- Sutherland WH, Manning PJ, Walker RJ, De Jong SA, Ryalls AR, Berry EA. Vitamin E supplementation and plasma 8‐isoprostane and adiponectin in overweight subjects. Obesity. 2007;15(2):386-91. doi: 1038/oby.2007.546. PMID: 17299112.
- Rimbach G, Moehring J, Huebbe P, Lodge JK. Gene-regulatory activity of α-tocopherol. Molecules. 2010;15(3):1746-61. doi: 3390/molecules15031746. PMID: 20336011. PMCID: PMC6257188.
- Zingg J-M. Molecular and cellular activities of vitamin E analogues. Mini reviews in medicinal chemistry. 2007;7(5):545-60. doi: 2174/138955707780619608. PMID: 17504191.
- Meydani SN, Meydani M, Blumberg JB, Leka LS, Pedrosa M, Diamond R, et al. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. The American journal of clinical nutrition. 1998;68(2):311-8. doi: 1093/ajcn/68.2.311. PMID: 9701188.
- Butcher GP RJ, Walker R, Krasner N, Jackson MJ. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification. Journal of hepatology. 1993;19(1):105-9. doi: 1016/s0168-8278(05)80183-7. PMID: 8301030.
- Cerletti C, Colucci M, Storto M, Semeraro F, Ammollo CT, Incampo F, Costanzo S, De Bartolomeo G, Portincasa P, Barone M, Di Castelnuovo A. Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease. British journal of nutrition. 2020;123(2):190-7. PMID: doi: 10.1017/S0007114519002484.
- Gan Y ML, How CB, Hay YK, Nesaretnam K, Kim-Tiu T, et al. Safety assessment of tocotrienol supplementation in subjects with metabolic syndrome: A randomised control trial. J Oil Palm Res. 2016; 28:34-43.
- Groenbaek K FH, Hansen M, Ring-Larsen H, Krarup HB. The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients. European journal of gastroenterology & hepatology. 2006;18(9):985-9. doi: 1097/01.meg.0000231746.76136.4a. PMID: 16894312.
- Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology. 2003 Aug 1;38(2):413-9. PMID: doi: 10.1053/jhep.2003.50316.
- Shen C-L WS, Yang S, Tomison MD, Abbasi M, Hao L, et al. A 12-week evaluation of annatto tocotrienol supplementation for postmenopausal women: safety, quality of life, body composition, physical activity, and nutrient intake. BMC complementary and alternative medicine. 2018;18(1):1-10. doi: 1186/s12906-018-2263-0. PMID: 29954374. PMCID: PMC6022510.
- Yasuko Ota VESIPFAoRMiH-IP N, 2004, Elsevier Inc., Nutrition Volume 20, Number 4, 2004.
- Suzanne May Quinn Tan T-RVEfPOTaIEiDaDNAPPICT N, 10, 1315, 2018. doi: 3390/nu10091315. PMID: 30227659. PMCID: PMC6164742.
- MAKOTO IKEDA Soaposdadsd TJEM, 2004, 203,353-357, 2004. doi: 1620/tjem.203.353. PMID: 15297742.
- Jyotsna A. Patil EoVESoBPiPSoGGoWMI IJCBA-J, 2012. PMID: 23543683 doi: 1007/s12291-012-0207-x. PMCID: PMC3358367.
- Saeian K, Bajaj JS, Franco J, Knox JF, Daniel J, Peine C, McKee D, Varma RR, Ho S, Midwest Hepatitis Study Group. High‐dose vitamin E supplementation does not diminish ribavirin‐associated haemolysis in hepatitis C treatment with combination standard α‐interferon and ribavirin. Alimentary pharmacology & therapeutics. 2004;20(10):1189-93. PMID: 15569122. doi: 1111/j.1365-2036.2004.02260.x.
- Hashemian Z, Hashemi A, Fateminasab M. The Benefits of vitamin E on liver function and the hemopoietic System in thalassemia Patients. Iranian journal of pediatric hematology and oncology. 2012;2(4):153. PMID: 24575256.
- Clerici C, Castellani D, Russo G, Fiorucci S, Sabatino G, Giuliano V, Gentili G, Morelli O, Raffo P, Baldoni M, Morelli A. Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. Anticancer research. 2004 Mar 1;24(2C):1255-60. PMID: 15154656.
- Golnaz Ekhlasi DsaVEshfeinfldAr d-b, placebo-controlled trial , J Res Med Sci. 2016; 21: 106. doi: 4103/1735-1995.193178. PMID: 28250783. PMCID: PMC5322689.
- Herbay AV SW, Niederau C, Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free radical research. 1997;27(6):599-605. doi: 3109/10715769709097863. PMID: 9455695.
- Pervez MA KD, Slehria AUR, Ijaz A. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. Complementary Therapies in Medicine. 2020; 52:102494. doi: 1016/j.ctim.2020.102494. PMID: 32951743.
- Marotta F, Yoshida C, Barreto R, Naito Y, Packer L. Oxidative‐inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation. Journal of gastroenterology and hepatology. 2007;22(5):697-703.PMID: doi: 10.1111/j.1440-1746.2007.04937.x.
- Han Y SJ-P, Ma A-L, Xu Y, Ding X-D, Fan J-G. Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose. Clinical drug investigation. 2014;34(1):1-7. doi: 1007/s40261-013-0136-3. PMID: 24081374.
- Meydani SN MM, Blumberg JB, Leka LS, Pedrosa M, Diamond R, et al. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. The American journal of clinical nutrition. 1998;68(2):311-8. doi: 1093/ajcn/68.2.311. PMID: 9701188.
- Billich N, Maugeri I, Calligaro L, Truby H, Davidson ZE. Weight management interventions that include dietary components for young people with chronic health care needs: A systematic review. Nutrition and Dietetics. 2022;79(1):94-109. doi: 1111/1747-0080.12698. PMID: 34369055.
- Sebastiani G, Saeed S, Lebouche B, de Pokomandy A, Szabo J, Haraoui L-P, et al. Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients. Aids. 2020;34(2):237-44. doi: 1097/QAD.0000000000002412. PMID: 31651429.
- Bernal-Reyes R, Escudero RB. Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report. Revista de gastroenterologia de Mexico. 2002;67(2):70-5. PMID: 12214337.
- Pervez MA, Khan DA, Ijaz A, Khan S. Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease. The Turkish Journal of Gastroenterology. 2018;29(2):170. doi: 5152/tjg.2018.17297. PMID: 29749323. PMCID: PMC6284694.
- Tan SMQ, Chiew Y, Ahmad B, Kadir KA. Tocotrienol-rich vitamin E from palm oil (tocovid) and its effects in diabetes and diabetic nephropathy: a pilot phase II clinical trial. Nutrients. 2018;10(9):1315. doi: 3390/nu10091315. PMID: 30227659. PMCID: PMC6164742.
- Cerletti C, Colucci M, Storto M, Semeraro F, Ammollo CT, Incampo F, et al. Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease. British Journal of Nutrition. 2020;123(2):190-7. doi: 1017/S0007114519002484. PMID: 31554528.
- Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. New England Journal of Medicine. 2000;342(17):1266-71. doi: 1056/NEJM200004273421707. PMID: 10781624.
- Tabei S, Fakher S, Djalali M, Javanbakht M, Zarei M, Derakhshanian H, et al. Effect of vitamins A, E, C and omega-3 fatty acids supplementation on the level of catalase and superoxide dismutase activities in streptozotocin-induced diabetic rats. Bratislava Medical Journal. 2015;116(2):115-8. doi: 4149/bll_2015_022. PMID: 25665478.
- Debbabi M, Nury T, Zarrouk A, Mekahli N, Bezine M, Sghaier R, et al. Protective effects of α-tocopherol, γ-tocopherol and oleic acid, three compounds of olive oils, and no effect of trolox, on 7-ketocholesterol-induced mitochondrial and peroxisomal dysfunction in microglial BV-2 cells. International journal of molecular sciences. 2016;17(12):1973. doi: 3390/ijms17121973. PMID: 27897980. PMCID: PMC5187773.
- Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study. Alimentary pharmacology & therapeutics. 2001;15(10):1667-72. doi: 1046/j.1365-2036.2001.01083.x. PMID: 11564008.
- Zhao L, Fang X, Marshall MR, Chung S. Regulation of obesity and metabolic complications by gamma and delta tocotrienols. Molecules. 2016;21(3):344. doi: 3390/molecules21030344. PMID: 26978344. PMCID: PMC6274282.
- Muid S, Hamid Z, Nawawi H. Tocotrienol rich fraction supplement reduces oxidative stress in non familial hypercholesterolaemia: beyond the lipid lowering capability. International Food Research Journal. 2018;25(4).
- Wong SK, Kamisah Y, Mohamed N, Muhammad N, Masbah N, Mohd Fahami NA, et al. Potential role of tocotrienols on non-communicable diseases: a review of current evidence. Nutrients. 2020;12(1):259. doi: 3390/nu12010259. PMID: 31963885. PMCID: PMC7019837.
- Herbay AV, Stahl W, Niederau C, Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free radical research. 1997;27(6):599-605. doi: 3109/10715769709097863. PMID: 9455695.
- Kamkwalala AR, Garg A, Roy U, Matthews A, Castillo-Mancilla J, Lake JE, et al. Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop. AIDS research and human retroviruses. 2021;37(11):807-20. doi: 1089/AID.2021.0059. PMID: 34405689. PMCID: PMC8817696.
|